UPMC and Kaiser Permanente have returned to contribute to a $100m series F round for the healthcare software developer, which has now achieved a valuation of more than $1bn.
US-based healthcare data services provider Health Catalyst closed a $100m series F round yesterday featuring healthcare and insurance provider UPMC and care consortium Kaiser Permanente.
The round was led by investment firm Orbimed and included Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures and Brent James, chief quality officer of health system Intermountain Healthcare, who joined Health Catalyst as strategic adviser last year.
UPMC and Kaiser Permanente contributed through respective corporate venturing units UPMC Enterprises and Kaiser Permanente Ventures. The…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
